Showing 2611-2620 of 4902 results for "".
DermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for tNew Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21573/New Frontiers in Skin Cancer Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-frontiers-in-skin-cancer-management/57249/Across the spectrum of diagnosis, prognostication, prevention, and treatment, advances in technology and therapeutics are reshaping how clinicians care for patients with skin cancer. This issue highlights innovations and insights that are changing the field and offers a glimpse of where skin cancerTeaching Hospitals Failing; Derm Toolkit Available for Practices
https://practicaldermatology.com/youngmd-connect/resident-resource-center/teaching-hospitals-failing-derm-toolkit-available-for-practices/20772/Coral Reefs Under Siege: Is Sunscreen to Blame?
https://practicaldermatology.com/topics/practice-management/coral-reefs-under-siege-is-sunscreen-to-blame/20543/What the science says about the effects of sunscreens on marine life.Periocular Sunscreen Use: An Essential Skincare Element
https://practicaldermatology.com/topics/skin-cancer-photoprotection/periocular-sunscreen-use-an-essential-skincare-element/20586/Five to 10 percent of all nonmelanoma skin cancers occur around the eyes. Use of sunscreens in this area is essential.Preparing for Private Equity: Benefits and Drawbacks
https://practicaldermatology.com/issues/september-2025/preparing-for-private-equity-benefits-and-drawbacks/37629/Over the past decade, the health care industry has emerged as a prime target for private equity (PE) investment.2020 Financial Benchmark Report: How Dermatology and Aesthetic Practices Fared in the COVID Era
https://practicaldermatology.com/topics/practice-management/2020-financial-benchmark-report-how-dermatology-and-aesthetic-practices-fared-in-the-covid-era/23693/How did your practice’s performance and growth compare to the rest of the industry?Expert Profiles of Fillers for Your Practice
https://practicaldermatology.com/topics/general-topics/expert-profiles-of-fillers-for-your-practice/21486/Experts discuss their experiences with various popular fillers and their benefits for patients.Taking a More Holistic View of the Pathogenesis of Acne
https://practicaldermatology.com/topics/acne-rosacea/taking-more-holistic-view-pathogenesis-acne/26539/Taking a More Holistic View of the Pathogenesis of Acne